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Conclusions: The intra-articular injections of autologous PRP showed a
reduction of pain, symptoms and a recover articular function in patients
affected by severe chondropaties of the knee. The patients 45 years old,
males, and without osteoarthritis showed a faster clinical improvement.
283 PATIENT RELEVANT OUTCOME 7 YEARS AFTER TOTAL HIP
REPLACEMENT FOR OA – A PROSPECTIVE STUDY
A.K. Nilsdotter1, S.L. Lohmander2. 1Department of Orthopedics,
Halmstad, SWEDEN, 2Department of Orthopedics, Clinical Sciences
Lund, Lund University, SWEDEN
Purpose: To investigate prospectively the patient-relevant outcome
7 years after total hip replacement (THR) for osteoarthritis (OA).
Methods: 219 consecutive patients (120 women) with primary OA, mean
age 71 (range 50−92) were assigned for THR at the Department of
Orthopedics at Halmstad Central Hospital, Sweden. They were examined
preoperatively, at 3, 6, 12 months, and at 4, 5 and 7 years postoper-
atively with the self-administered questionnaires SF-36 and WOMAC.
Supplementary questions regarding postoperative complications, general
co-morbidity, social circumstances and patient satisfaction were asked
at the three last follow-ups. A matched reference group, 117 subjects
(67 women), mean age 72 (range 52−92) without hip complaints were
recruited from the community and investigated at the same times.
Results: 151/170 (89%) of the patients and 65/74 (88%) of the reference
group participated at the 7 year follow-up. The best postoperative result
was reported one year postoperatively. At that time the only difference
between the two groups was seen in SF-36 physical function (PF), where
the patients scored worse than the reference group (54 vs. 69). At the
later follow-ups there was a successive decline in SF-36 PF compared
to the reference group. However, patients did not report worse WOMAC
function than the reference group. There was no difference in frequency
of co-morbid conditions (19% vs. 31% p< 0.08) between those operated
and the reference group, but those operated were in greater need of
walking aid (46% vs.8% p< 0.0001) and reported more regional pain and
widespread pain (68% vs. 53% p< 0.05). However, 97% of the patients
were satisﬁed with pain relief and 96% with improved physical function
at the 7 year follow-up.
Conclusions: Total hip replacement for osteoarthritis is a successful
procedure. This study shows that in an unselected cohort the patients
experience the same health-related quality of life as a matched reference
group 7 years after THR except for physical function where the patients
score worse. This may be explained by musculoskeletal co-morbidities
such as progress in generalized OA. The difference in outcome between
SF-36 PF and WOMAC function may be explained by the disparity
between a generic and a disease and extremity speciﬁc measurement
where SF-36 PF represents the entire physical function.
284 AN ORAL RECOMBINANT FORM OF SALMON CALCITONIN
SUPPRESSES BOTH BONE RESORPTION AND CARTILAGE
DEGRADATION
I. Byrjalsen, K. Henriksen, B.J. Riis, M.A. Karsdal, C. Christiansen.
Nordic Bioscience, Herlev, DENMARK
Purpose: Calcitonin suppresses bone resorption, and appears to have
an effect on cartilage degradation, and therefore has been speculated to
be useful for treatment of osteoarthritis. However, the pharmacodynamic
proﬁle of sCT on cartilage degradation is not clear. The aim of the study
was to assess the effect of bi-daily dosing with 0.8mg of oral salmon
calcitonin (sCT) given in the morning at 08:00 and pre-dinner at 17:00
with respect to reduction of both bone resorption (CTX-I) and cartilage
degradation (CTX-II).
Methods: Participants were from a randomized, double-blind, placebo-
controlled 14-day treatment study including postmenopausal women and
men (n=73) suffering from osteoarthritis (OA). One of the treatment arms
comprised administration of 0.8mg of oral sCT given twice daily with one
dose given in the morning to fasting individuals at 08:00, and one dose
given pre-dinner at 17:00 (n=26). On treatment day 1 and day 14, blood
samples were taken before drug intake, and at 10, 15, 30, 45 minutes,
and 1, 2, and 4 hours for plasma sCT measurements. Urine samples were
collected at baseline, at 2, 4, 6, 8, 11 and 13 hours. The absorption of
calcitonin was assessed by measurement of plasma sCT concentrations,
and bone resorption by the biochemical marker of urine CTX-I (C-terminal
telopeptide of collagen type I). Cartilage degradation was assessed by
urine CTX-II (C-terminal telopeptide of collagen type II).
Results: Dosing with oral sCT resulted in a signiﬁcant increase in
plasma sCT levels, which was eliminated within two hours after dosing. In
alignment, urine CTX-I was suppressed over placebo with an AUC0−8hrs of
−425 [%×Hrs] at the 8:00 dose compared to −105 [%Hrs] in the placebo
group (p = 0.003). The suppression of CTX-I was present throughout the
13 hours sampling period. For CTX-II a suppression of the AUC0−8hrs
of −355 [%Hrs] was observed compared to −60 [%Hrs] in the placebo
group (p< 0.007). The suppression of CTX-II was not alleviated within
the 13 hour observation period. The results from the day 14 analysis
were all in the same magnitude.
Conclusions: We found that an oral recombinant form of salmon calci-
tonin signiﬁcantly suppressed both bone resorption and cartilage degra-
dation within a short time span. These studies warrant further investiga-
tion of the potential use of oral calcitonin for treatment of osteoarthritis.
285 CLINICAL, RADIOLOGICAL AND IMMUNOGENETIC
ASPECTS OF EROSIVE OSTEOARTHRITIS (EOA) OF THE
HAND IN A GROUP OF PATIENTS FOLLOWED FOR 2 YEARS
FROM A SINGLE CENTER
M. Frigato1, R. Ramonda1, C. Campana1, C. Contessa1,
P. Frallonardo1, V. Barbieri2, A. Piccoli3, P. Zanovello2, V. Bronte2,
L. Punzi1. 1Rheumatology Unit, University of Padova, Padova,
ITALY , 2Oncology Department, University of Padova, Padova, ITALY,
3Nephrology Unit, University of Padova, Padova, ITALY
Purpose: EOA is believed to be a clinical subset of OA most often
involving the hands of middle-aged women and characterised by a
frequent aggressive clinical course. In EOA, pain and inﬂammation persist
or recur for many years, in contrast with the more common nodal OA
(non-EOA), in which they are usually found only at the disease onset.
Despite its severity, EOA is still poorly deﬁned, so it is debated whether
or not it belongs to OA or is a separate entity. Since very few reports are
available concerning the various features of EOA, the aim of our study
was to analyse its clinical, radiological and immunogenetic aspects in a
cohort of 109 patients observed in our unit, and compare these with a
series of non-EOA patients
Methods: A total of 162 patients, 109 with EOA and 53 with non-EOA
were analysed. All patients satisﬁed the Altman criteria for OA of the hand.
Patients showing at least two erosions in interphalangeal (IP) joints were
included in EOA, while patients with erosions in metacarpophalangeal
joints were excluded. In all patients (EOA and non-EOA) we evaluated
the number of active joints (AJ) (swollen and painful), number of joints
involved (NJI) and the radiographic score (RS) by Kallman scale. In
24 patients with EOA followed for at least two years, we evaluated the
outcome for clinical and radiological aspects. Patients underwent hand
X-rays at the baseline and after a two year period and assessment was
done by two experienced operators. The clinical examination was also
performed at the ﬁrst visit and after two years. In all patients HLA typing
was determinated on blood samples (GenoPrepTM DNA from Blood Kit
by GenoVision A.S, Norway; PCR Master Mixes).
Results: No difference was observed between EOA and non-EOA for age
and disease duration. The mean number of erosions in EOA was 4.01
(±2.4). Both the number of AJ and the RS were higher in EOA (6.3±2.4
and 65.9±26.5, respectively) than in non-EOA (4.5±4.6, p = 0.02 and
32.1±19.1, p< 0.001, respectively).
In the subset of 24 patients with highest RS at baseline and more severe
joint involvement, we observed a signiﬁcant worsening in both radiological
and clinical parameters (RS at baseline vs two years p< 0.001; NJI vs
NJI2 p< 0.001; AJ vs AJ2 p< 0.012). Concerning HLA, in this subgroup
of patients we observed higher frequency of the allele A24 (29.1%), A2
(45.8%), DRB1 11 (37.5%), DRB 07 (16.6%).
Conclusions: EOA clearly differs from non-EOA in many aspects, in-
cluding the higher AJ and RS, so conﬁrming its severity. We observed a
more aggressive clinical course in the subgroup of patients who presented
higher scores at the ﬁrst visit. The association with some HLA alleles, in
particular A2, A24, DRB 07 and 11, suggests a more severe subset of
patients. Further studies are needed to conﬁrm these data.
286 DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS (DISH) AT,
OR BEFORE, THE FIFTH DECADE OF LIFE
R. Mader1, I. Lavi2. 1Ha’Emek Medical Center, Afula, ISRAEL, 2Carmel
Medical Center, Haifa, ISRAEL
Purpose: At present, the diagnosis of DISH is based on characteristic
ﬁnding in radiographs of the thoracic spine, which are not often ordered.
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Due to the clinical and metabolic implications of such a diagnosis, and for
research purposes, diagnosis in earlier age may be beneﬁcial. We tried
to identify factors, in clinical practice, that might be useful to increase the
index of suspicion for this disorder, in a relatively young age.
Methods: From our cohort of 140 patients with DISH, we identiﬁed
18 patients (12.8%) who were diagnosed before the age of 50 years
(group A). This group was compared to 20 patients of similar age with
osteoarthritis (group B), and 24 patients with DISH diagnosed after the
age of 60 years (group C). All the patients with DISH met the Resnick
classiﬁcation criteria, and all OA patients did not have radiological ﬁndings
suggestive of DISH. Data collection included demographic characteris-
tics, body region of main complaint (ie upper or lower limbs, cervical,
thoracic, or lumbar spine, chest, hips and shoulders girdle), clinical or
radiographic evidence for enthesopathies or tendonitis, length of follow-
up, BMI, serum lipid proﬁle, family history of diabetes mellitus (DM),
hypertension (HTS), and gout. The presence of ischemic heart disease
(IHD), cerebral vascular disease (CVD), DM, and HTS, were recorded at
presentation and during the follow-up period. The use of blood pressure
lowering agents, anti diabetic medications, lipid lowering agents, aspirin
or other antiplatelet medications, allopurinol, and anti anginal medications
were also recorded at presentation and during the follow-up period.
Results: Gender distribution was similar in all groups. The mean age at
presentation for groups A, B, and C was 45, 50 and 69 years respectively,
and the mean follow-up was 6.6, 7.9, and 4.3 years respectively. Patients
in group A compared to group B, had statistically signiﬁcant more pain
in the lumbar and thoracic spine (p = 0.001 and 0.016 respectively), and
were more likely to be obese (BMI 30, p = 0.014). They were also more
likely to have a ﬁrst degree relative with HTS and DM (p=0.015 and 0.05
respectively). Enthesopathies and/or tendonitis were signiﬁcantly more
common in group A (p = 0.028). Patients in group A were more likely
to have DM and were more often prescribed anti diabetic medications
during follow-up, although these did not reach statistical signiﬁcance. No
statistical differences were observed for any of the investigated items
between group A and group C except for a signiﬁcantly higher occurrence
of HTS in group C.
Conclusions: Individuals in their ﬁfth decade of life are likely to be
affected by DISH if they are obese, have a ﬁrst degree relative with either
HTS or DM, complain of lumbar or thoracic spinal pain, and are affected
by enthesopathies or tendonitis. These individuals have a tendency to
have or develop DM. The variables examined in this study, in patients
with DISH, did not differ between the age groups.
287 CORRELATION BETWEEN POSTURAL BALANCE, MUSCLE
STRENGTH, PAIN AND HIP FUNCTION IN PATIENTS
WITH OSTEOARTHRITIS BEFORE AND AFTER TOTAL
HIP ARTHROPLASTY: A PROSPECTIVE CONTROLLED
FOLLOW-UP STUDY
I. Yuksel1, S. Citaker1, D. Kaya1, N. Tugay2, G.I. Guvendik1, B. Atilla1,
M. Tokgozoglu1. 1Hacettepe University, Ankara, TURKEY, 2Mugla
University, Mugla, TURKEY
Purpose: Improvement of postural stability is one of the most important
rehabilitative goals to prevent falling and consequent loosening or dislo-
cation of the prosthesis in patients with total hip arthroplasty (THA). Some
of the previous studies revealed that despite capsulectomy, no signiﬁcant
loss was observed in proprioceptive sense in THA patients. However,
balance deﬁcits and abductor muscle weakness generally persisted. The
aims of this study were (1) to compare the postural balance and lower
extremity muscle strength in THA patients with healthy subjects and (2) to
evaluate the factors – aside from proprioception – related to postural
stability in patients with hip osteoarthiritis, before and after THA.
Methods: A total of 20 THA patients and 20 age-and sex- matched
healthy controls were included in this prospective controlled follow-up
study. Balance and related parameters were evaluated before THA and
then 6 weeks, three months and six months postoperatively. Balance
was examined using stabilometry. Muscle strength (maximal volunter
contraction) of the lower extremity was measured with strain gauge
myometer. Other parameters analysed as possible causes of balance
impairment were; range of motion, leg length discrepancy, pain intensity
and Harris Hip Score. All of the patients were given supervised postop-
erative physiotherapy during their hospitalization. They were also given
a home exercise program at the time of discharge. Data were evaluated
using Spearman correlation analysis, and t tests.
Results: Compared to the healthy controls, patients with THA showed
signiﬁcant balance deﬁcit at all measurements (p< 0.05). No statistically
signiﬁcant difference was found between the preoperative and follow-up
balance index scores in the THA group (p> 0.05). Some of the big mus-
cles – especially the hip abductors – of the lower extremities were found
to be signiﬁcantly weaker in osteoarthritic hips (preoperatively) than that
of their contralateral legs (p< 0.05) and also than that of control subjects
(p< 0.05). At six weeks after THA, signiﬁcant deﬁcits were observed in
muscle strength as compared to preoperative values (p< 0.05). These
muscles became signiﬁcantly stronger than preoperative levels at the
end of the third and sixth months but especially hip abductors remaied
weaker than that of controls. Signiﬁcant correlations were found between
the strength of hip and knee ﬂexor muscles and balance index score
(r = −0.577; r = −0.641) at postoperative three months and also between
the knee extensor muscle strength and balance index score (r = −0.566) at
six months. Patients with stronger muscles had better postural stability. In
the THA group, Harris Hip Score was correlated with the balance index
score (r = −0.877) at three months follow-up. No correlation was found
between the balance and other variables.
Conclusions: As muscle strength and hip function was found to be a
strong predictor of better balance performance, rehabilitation programs
that focus on strengthening of the hip muscles as well as postural control
and proprioception exercises can improve the balance of these patients
and prolong survival after prosthesis.
288 HAND OSTEOARTHRITIS IN OLDER WOMEN IS ASSOCIATED
WITH CAROTID AND CORONARY ATHEROSCLEROSIS: THE
AGES-REYKJAVIK STUDY
H. Jonsson1, G.P. Helgadottir2, T. Aspelund2, G. Eiriksdottir3,
S. Sigurdsson3, T. Ingvarsson4, T.B. Harris5, L. Launer5, V. Gudnason2.
1Landspitalinn University Hospital, Reykjavik, ICELAND, 2University of
Iceland, Reykjavik, ICELAND, 3Icelandic Heart Association, Reykjavik,
ICELAND, 4Akureyri Central Hospital, Akureyri, ICELAND, 5National
Institute on Aging, Bethesda, MD, USA
Purpose: There is some evidence that atherosclerosis may contribute to
the initiation or progression of osteoarthritis (OA). To test this hypothesis,
we compared the presence and severity of hand osteoarthritis (HOA),
scored from photographs, with markers of atherosclerotic vascular dis-
ease in an elderly population.
Methods: The AGES-Reykjavik Study is a population-based multidis-
ciplinary study of aging in the elderly population of Reykjavik. The
participants were 2264 males, mean age 76±6, and 3078 females, mean
age 76±6. Evidence of HOA was recorded from high quality digital
photographs and given a global score of 0−4 based on the number
and the severity of affected DIP, PIP and CMC1 joints. The measures of
atherosclerosis included carotid intimal thickness and plaque severity by
ultrasound, coronary and aortic calciﬁcations by computed tomography,
and reported cardiac and cerebrovascular events for association.
Results: After adjustment for confounders including age and smoking,
both carotid plaque severity (CPs), and coronary calciﬁcations (CAC),
were signiﬁcantly associated with the presence of HOA in females
with an odds ratio of 1.42 (1.14−1.76, p = 0.0016) for having coronary
calciﬁcations, and 1.25 (1.04−1.49, p = 0.0159) for having moderate or
severe carotid plaques. Both CPs (Moderate or severe) and CAC (pres-
ence/absence) also exhibited signiﬁcant linear trends in relation to HOA
severity in females (p = 0.00002 and p=0.027 respectively for trend). No
signiﬁcant associations were seen in males. Despite this evidence of
increased atherosclerosis, females with HOA did not report proportionally
more previous cardiovascular or cerebrovascular events.
Conclusions: These results indicate a linear relationship between the
severity of HOA and atherosclerosis in older females. Thus, the patho-
logical process of HOA seems to have some components in common with
atherosclerosis. Prospective studies may help clarifying the mechanisms
of this relationship.
289 MAGNITUDE OF THE SYMPTOMATIC AT 3, 6 AND
12 MONTHS AFTER TOTAL ARTICULAR REPLACEMENT IN
HIP AND KNEE OSTEOARTHRITIS: A SYSTEMATIC REVIEW
AND META-ANALYSIS
J.C. Ferna´ndez-Lo´pez1, L. Gossec2, M. Dougados2. 1Rheumatology
Division. Clinical Research Unit, CH Universitario Juan Canalejo,
Corun˜a, SPAIN, 2Rene´-Descartes University, Medicine Faculty; AP-HP,
Cochin Hospital, Rheumatology B Department, Paris, FRANCE
Purpose: Despite the fact that Total Articulation Replacement (TAR) is
proposed as the optimal therapy in advanced disease Osteoarthritis (OA),
